Scientific Validation

Integrated Study Results and Compound Validation

Scientific Foundation
of AMH Biotech Formulations

AMH Biotech formulations are developed using a multi-step scientific approach integrating computational modeling, binding validation, and in vitro evaluation. This framework is designed to identify and validate targeted interactions between high-purity flavonoids and biologically relevant protein structures.

Scientific Validation

Molecular and Cellular Findings

vira Shield (1)
Computational Modeling

Key Findings:

1. Multiple flavonoids demonstrated favorable binding conformations
2. Defined binding pockets and interaction residues were identified
3. Select compounds showed consistent interaction patterns across multiple targets

vira Shield (1)
Binding Validation (SPR)

Interpretation:

1. Confirms real-world interaction beyond computational prediction
2. Provides quantitative binding characteristics
3. Supports target-specific engagement

vira Shield (1)
Transdermal Absorption Assurance

Results Summary:

1. Minimal cytotoxicity observed in mammalian cell models
2. Supports selective interaction profile
3. Indicates suitability for further investigation

vira Shield (1)
Compound Selection Strategy

Lead Compounds Identified:

1. Quercetin
2. Quercitrin
3. EGCG
4. Hesperidin

Scientific Positioning Statement

The integration of computational modeling, binding validation, and in vitro evaluation supports a
mechanism-based approach to formulation development using high-purity flavonoids.

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. These product is not intended to diagnose, treat, cure, or prevent any disease.

Main Menu